Clinical Trials Directory

Trials / Unknown

UnknownNCT05151601

Combined Human Milk Oligosaccharides (HMOs) and Probiotics Intervention for Children With Autism

The Effect of a Combination of Human Milk Oligosaccharides (HMOs) and Probiotics on Behavioural Change in Children With Autism Spectrum Disorder (ASD).

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
The University of Queensland · Academic / Other
Sex
All
Age
5 Years – 12 Years
Healthy volunteers
Not accepted

Summary

This research project will investigate if a supplement containing a unique combination of prebiotics and probiotics can influence behaviour in children diagnosed with autism spectrum disorder. The study will use a combination of human milk oligosaccharides (HMOs, prebiotics) and probiotics as an oral powder.This clinical trial will have two consecutive phases. Phase 1A is an 8-week randomised, double-blinded, placebo-controlled trial. Participants will be recruited and randomised (1:1) to receive either the investigational product (treatment group, n=30) or the placebo (control group, n=30). Phase 1B is an 8-week open-label study. All participants that complete Phase 1A will move into Phase 1B (n=60). This allows all participants to receive the investigational product and will provide additional information on increased duration of treatment.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTExperimental2 x sachets per day
OTHERPlacebo2 x sachets per day

Timeline

Start date
2022-05-17
Primary completion
2023-04-16
Completion
2023-12-31
First posted
2021-12-09
Last updated
2023-06-28

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT05151601. Inclusion in this directory is not an endorsement.